Showing 1221-1240 of 8875 for: Cochrane Systematic Reviews Back
- Bromocriptine versus levodopa in early Parkinson's disease
Cochrane Systematic Reviews, 17-Oct-2007
Drugs that mimic dopamine as bromocriptine were introduced as monotherapy or in combination with LD in the hope that this approach would prevent or delay the onset of motor complications in patients with Parkinson's disease (PD). However, hitherto, the ro
- Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease
Cochrane Systematic Reviews, 17-Oct-2007
Drugs that mimic dopamine, such as bromocriptine (BR), were introduced as monotherapy or in combination with levodopa (LD) in the hope that this approach would prevent or delay the onset of motor complications in patients with Parkinson's disease (PD). Ho
- Bromperidol decanoate (depot) for schizophrenia
Cochrane Systematic Reviews, 14-Nov-2012
Antipsychotic drugs are the mainstay treatment for schizophrenia. Long-acting depot injections of drugs such as bromperidol decanoate are extensively used as a means of long-term maintenance treatment.
- Bronchial thermoplasty for moderate or severe persistent asthma in adults
Cochrane Systematic Reviews, 5-Mar-2014
Bronchial thermoplasty is a procedure that consists of the delivery of controlled radiofrequency-generated heat via a catheter inserted into the bronchial tree of the lungs through a flexible bronchoscope. It has been suggested that bronchial thermoplasty
- Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD
Cochrane Systematic Reviews, 29-Aug-2016
Bronchodilators are a central component for treating exacerbations of chronic obstructive pulmonary disease (COPD) all over the world. Clinicians often use nebulisers as a mode of delivery, especially in the acute setting, and many patients seem to benefi
- Bronchodilators for bronchiolitis
Cochrane Systematic Reviews, 17-Jun-2014
Bronchiolitis is an acute, viral lower respiratory tract infection affecting infants and is sometimes treated with bronchodilators.
- Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants
Cochrane Systematic Reviews, 13-Dec-2016
Chronic lung disease (CLD) occurs frequently in preterm infants. Bronchodilators have the potential effect of dilating small airways with muscle hypertrophy. Increased compliance and tidal volume and decreased pulmonary resistance have been documented wit
- Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 23-Feb-2017
In the recent years, a variety of bronchoscopic lung volume reduction (BLVR) procedures have emerged that may provide a treatment option to participants suffering from moderate to severe chronic obstructive pulmonary disease (COPD).
- Bronchoscopy‐guided antimicrobial therapy for cystic fibrosis
Cochrane Systematic Reviews, 17-Sep-2018
Early diagnosis and treatment of lower respiratory tract infections are the mainstay of management of lung disease in cystic fibrosis. When sputum samples are unavailable, treatment relies mainly on cultures from oropharyngeal specimens; however, there ar
- B‐type natriuretic peptide‐guided treatment for heart failure
Cochrane Systematic Reviews, 22-Dec-2016
Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention. Outcomes for patients with heart failure are highly variable; howe
- Buccal or sublingual misoprostol for cervical ripening and induction of labour
Cochrane Systematic Reviews, 18-Oct-2004
This is one of a series of reviews of cervical ripening and labour induction using standardised methodology. Misoprostol administered by the oral and sublingual routes have the advantage of rapid onset of action, while the sublingual and vaginal routes ha
- Budesonide at different doses for chronic asthma
Cochrane Systematic Reviews, 24-Apr-2000
Inhaled budesonide (BUD) is available in a range of doses for treating chronic asthma.
- Budesonide for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 29-May-2015
Corticosteroids are commonly used for the induction of remission in Crohn's disease. However, traditional corticosteroids can cause significant adverse events. Budesonide is an alternative glucocorticoid with limited systemic bioavailability.
- Budesonide for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 21-Aug-2014
Corticosteroids are effective for induction, but not maintenance of remission in Crohn's disease. Significant concerns exist regarding the risk for adverse events, particularly when corticosteroids are used for long treatment courses. Budesonide is a gluc
- Budesonide versus placebo for chronic asthma in children and adults
Cochrane Systematic Reviews, 25-Oct-1999
Inhaled budesonide is a widely used inhaled corticosteroid for asthma.
- Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children
Cochrane Systematic Reviews, 19-Jul-2019
Fluid therapy is one of the main interventions provided for critically ill patients, although there is no general consensus regarding the type of solution. Among crystalloid solutions, 0.9% saline is the most commonly administered. Buffered solutions may
- Buflomedil for acute ischaemic stroke
Cochrane Systematic Reviews, 20-Jul-2015
Few strategies are effective for the treatment of acute ischaemic stroke. Buflomedil is a vasoactive agent that has been used for peripheral arterial diseases. Research studies have suggested that buflomedil may have beneficial effects in people with cere
- Buflomedil for intermittent claudication
Cochrane Systematic Reviews, 28-Mar-2013
Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical effic
- Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Cochrane Systematic Reviews, 10-Aug-2011
Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. The role of pharmacotherapy for IBS is limited and focused mainly on symptom control.
- Buprenorphine for managing opioid withdrawal
Cochrane Systematic Reviews, 21-Feb-2017
Managed withdrawal is a necessary step prior to drug-free treatment or as the endpoint of substitution treatment.
